Kenya receives new type of anti-tuberculosis drugs – Radio National



Download Video

A new drug-resistant tuberculosis vaccine will be launched in February and March this year at low cost in the five most affected countries in Africa.

Ethiopia, Ghana, Kenya, Mozambique, and Zimbabwe will be the first of a total of 12 nations to offer the new drug at a cost of 1,647 shillings equivalent to $ 15 courtesy of funding from Unitaid, the president’s emergency response plan. AIDS (PEPFAR), and an international fund to fund the fight against AIDS, tuberculosis and Malaria.

Other states are also expected to receive the drug with the help of the PEPFAR program and the international treasury.

The drug, which is a combination of two doses of rifapentine and isoniazid, reduces the number of ingested weekly drugs from nine to three and prevents tuberculosis in those who are at greater risk of contracting the disease.

According to Dr. Teresa Kasaeva, director of the International Tuberculosis Program at the World Health Organization, provides adequate treatment for up to three million patients this year.


Kenya receives new type of anti-tuberculosis drugs – Radio National

Source link

About admin

Recommended for you

Leave a Reply

Your email address will not be published. Required fields are marked *